MedTrace Logo

PET-CT in the Management of Patients With Stage III or IV Metastatic Melanoma

NCT00828126 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 38

Last updated 2012-03-28

No results posted yet for this study

Summary

The goal of this clinical research study is to learn how often using a positron emission tomography-computed tomography (PET-CT) scan in addition to a standard computed tomography (CT) scan will change the surgical plan in patients with metastatic melanoma.

Conditions

Interventions

PROCEDURE

PET-CT Scan

Positron emission tomography-computed tomography (PET-CT) scan performed within 30 days of contrast-enhanced CT.

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Yulia Bronstein, MD · UT MD Anderson Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00828126 on ClinicalTrials.gov